Medical Ethics
RSSArticles
-
Calendar
-
Correction: Tubersol contains latex rubber stopper
-
‘It was like being handed a death sentence,’ nurse says
-
Preventing sticks: Safety devices aren’t enough
-
Washington state takes aim at ergo hazards
-
Special needlestick CD offer for HEH subscribers
-
Should IRBs standardize payments to subjects?
-
Key finance question: Is relationship covered?
-
Vaccine, drug development link IRBs and researchers
-
Ethics of high-tech, high-cost interventions
It is important that the medical community understands that the cardiology and cardiac surgery communities are confronting end-of-life issues and the need to make appropriate treatment decisions based on an assessment of the likelihood that it will make a difference in a positive way, usually in a frail, sick, elderly patients life, argues Patrick OGara, MD, FACC, president-elect of the American College of Cardiology and executive medical director of the Carl J. and Ruth Shapiro Cardiovascular Center at Brigham and Womens Hospital in Boston.